Sars, Cov-II virus antigen - Home test
Product Name
HWTS, RT062IA / B / C-Sars-Cov-II Virus Antigen Part (Colloidal Aurum modum) -nasal
Certificatorium
Ce1434
Epidemiology
Coronavirus Morbus MMXIX (CoviD-XIX), est pneumonia fecit per infectio cum nova coronavirus nomine gravi acuti respiratoriorum corona-virus II (Sars, Cov- II). Sars, Cov-II est novum coronavirus in β genus, involvitur particulas in circuitu vel ovali, cum diameter a LX NM ad CXL NM. Humanum est plerumque susceptibilis ad Sars, Cov-II. Pelagus fontes infectio sunt confirmata Covi-XIX aegris et asymptomatic carrier de Sarscov-II.
Volume studium
In perficientur de antigen deprehendatur ornamentum est aestimari in DLIV aegris nasi swabs collecta ex signa suspicatur de Covi-XIX intra VII dies post indicium impetum comparari ad Rt-PCR Assay. In perficientur de Sars, Cov- II AG Test Ornamentum est quod sequitur:
Sars-Cov-II virus antigen (investigational Reagent) | Rt-PCR Reagent | Summa | |
Positivus | Negans | ||
Positivus | 97 | 0 | 97 |
Negans | 7 | CDL | CDLVII |
Summa | CIV | CDL | DLIV |
Sensibilitas | 93,27% | 95.0% CI | 86,62% - 97.25% |
Specifica | 100.00% | 95.0% CI | 99.18% - 100.00% |
Summa | 98,74% | 95.0% CI | 97.41% - 99.49% |
Technical parametri
Storage temperatus | IV ℃ -30 ℃ |
Sample Type | Nasi swab samples |
PLUTEUM vitae | XXIV menses |
AUXILA | Non requiratur |
Extra Consumables | Non requiratur |
Deprehensio Tempus | 15-20 min |
Specifica | There is no cross-reactivity with pathogens such as human Coronavirus ( HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63), Novel influenza A H1N1 (2009), seasonal influenza A (H1N1, H3N2, H5N1, H7N9) , B (Yamagata, Victoria), Synytic virus respiratorii A / B, parainfluenza virus (I, II et III), Rhinovirus (A, B, C), adenovirus (I, II, III, 4,5, VII, LV, III, IV, VII, VII). |
ADMODO
I. sampling
●Leniter inserere totam mollis tip de swab (plerumque 1/2 ad 3/4 de inch) in unum naribus, usura medium pressura, fricare in swab contra omnes intra muros tuos naribus. Fac saltem V magnum circulos. Et quisque nare debet esse swebbed circiter XV seconds.urtsing eundem swab, repetere idem in alia nare.

●Sample solvit.Tinget in swab omnino in sample extraction solutio; Frange in swab in fractione punctum, relinquens molle finem in tubo. Screw in cap, invertunt X temporibus et posuit tubo ad stabilem est.


II. Experito test
Pone III guttae de processionaliter extractum sample in specimen foraminis deprehendatur card, cochlea cap.

III. Legit effectus (15-20s)
